Cinacalcet for the Treatment of Humoral Hypercalcemia of Malignancy: An Introductory Case Report with a Pathophysiologic and Therapeutic Review

Cinacalcet for the Treatment of Humoral Hypercalcemia of Malignancy: An Introductory Case Report with a Pathophysiologic and Therapeutic Review

Hypercalcemia is an ominous development in the course of malignancy associated with a mean survival of only several months. A majority of cases of hypercalcemia are related to humoral hypercalcemia of malignancy (HHM), where hypercalcemia is caused by increased levels of circulating parathyroid horm...

Full description

Bibliographic Details
Main Authors: Michael Sheehan, Sabo Tanimu, Yusuf Tanimu, Jessica Engel, Adedayo Onitilo
Format: Article
Language:English
Published: Karger Publishers 2020-03-01
Series:Case Reports in Oncology
Subjects:
cinacalcet
humoral hypercalcemia of malignancy
pathophysiology
Online Access:https://www.karger.com/Article/FullText/506100

Similar Items

Similar Items